Hematology Diagnostics Market By Restorative Material Product Type (Hematology Instruments, Hematology Consumables), By End-user Segment (Diagnostic Laboratories, Hospitals & Clinics, Academic and Research Institutions) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

During the forecast period, the Hematology Diagnostics Market will exhibit profitable growth.

The global hematology diagnostics market is rapidly expanding; it was worth $3,167.2 million in 2017 and is expected to reach $5,288.3 million by 2026. Increasing blood donation procedures and rising incidences of blood disorders, along with enhanced diagnostics and hematology testing technologies, drive the overall hematology diagnostics market's growth.

A new technological evolution in automated hematology analyzers would also drive the overall market. Additionally, new standardized, automated sample collection, data processing, identification and testing, and ordering of new tests, among other processes, will further spur revenue growth during the forecast period.

Market Synopsis

The hematology consumables segment is expected to dominate the global market during the forecast period.

Overall, sales of hematology consumables are expanding significantly on a global scale. It is anticipated to continue its dominance during the forecast period. Rising demand for consumables, along with the diagnosis of blood disorders and other infections, will grow prominently.

Moreover, increasing volumes of diagnostic tests owing to growing awareness and incidence are also driving the market growth. A wide range of reagents and kits, stains, and others in the consumables segment incorporates experts to meet the dynamic demand.

The instrument segment is further divided into analyzers, flow cytometers, and others. Increased automation, which offers high reliability, sensitivity, and specificity along with higher safety and ease of operation, is estimated to be the primary growth factor driving the hematology instruments segment globally.

The diagnostic laboratories segment is expected to register higher growth by the end of 2026.

Diagnostic laboratories in the end-user segment are predicted to expand at a significant CAGR during the forecast period. The rising number of multispecialty diagnostic centers and the availability of advanced hematology products are fueling demand globally. Additionally, the automation of diagnostic tools is anticipated to reduce the overall cost of blood testing.

The rise in partnerships among market players and diagnostic laboratories is one factor that is likely to drive market growth. The adoption of fully automated analyzers, along with enhanced prognosis, infectious disease monitoring, diagnosis, and preliminary screening processes, will drive growth in the end-user segment.

Increasing demand for advanced equipment and the presence of established players hold North America in a dominant position.

North America will account for the largest revenue share of the global hematology diagnostics market. The use of advanced technologies for point-of-care tests, as well as rising incidences of diseases such as blood cancers, acute infectious diseases, liver diseases, and spleen diseases, are factors boosting growth in North America.

Asia Pacific is expected to grow at a significant pace owing to new technology expansion and the adoption of advanced diagnostic instruments. Enhanced healthcare services, along with improved government initiatives, will have a positive impact on the hematology diagnostics market.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the hematology diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt., and others. Furthermore, new product launches and technology expansion in diagnostic laboratories will drive market growth in the future.

The rising prevalence of blood disorders and other target diseases, the dynamic shift from manual to automated hematology testing, and the competitive advantages offered by commercial service providers in developing countries will all contribute to the market's overall growth on a global scale.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segment

The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities to provide a more comprehensive understanding of the global hematology diagnostics market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

• What are the current market trends and dynamics in the hematology diagnostics market, and what are the valuable opportunities for emerging players?
• How has laboratory automation affected the dynamics of the hematology diagnostics market?
• What are the impact of fully automated analyzers and their consumption in developed markets?
• Which segment accounts for the fastest CAGR during the forecast period?
• What is the impact of target diseases and other infectious diseases on the hematology diagnostics market?
• What are the market trends and dynamics in emerging markets such as India, Mexico, China, South Africa, Brazil, and the Gulf nations?

Frequently Asked Question: